Physician profile

Mark M Gajjar

Interventional Cardiology · Kyle, TX

NPI 1942519319

$78,476.29

in general payments reported to CMS, 2019-2025

21 companies · $49K in 2025

The $49K reported for 2025 was more than what 97% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).

See the full distribution for Interventional Cardiology

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Consulting Fee$41,781.77
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program$10,500.00
Food and Beverage$9,704.53
Travel and Lodging$9,120.91

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Abbott Laboratories $48,712.85 2020-2025 Amplatzer Talisman, Mitraclip, Jeti All In One Non-Sterile Kit
Edwards Lifesciences Corporation $20,605.71 2019-2025 Edwards Sapien 3 Transcatheter Heart Valve (Thv), Edwards Sapien 3 Ultra Transcatheter Heart Valve, Sapien 3 Ultra Resilia
Medtronic, INC. $3,489.98 2021-2025 Corevalve Evolut R, Harmony
Medtronic Vascular, INC. $1,227.19 2019-2020
Abiomed $941.31 2019-2024 Impella
W. L. Gore & Associates, INC. $775.06 2019
Boston Scientific Corporation $583.51 2019-2023 Watchman
Inari Medical, INC. $490.90 2022-2023 Ct Thrombectomy System Kit, Flowtriever Catheter, S
Ancora Heart, INC. $365.72 2024 Accucinch
Cardiovascular Systems INC. $230.65 2019-2021
Terumo Medical Corporation $218.55 2020-2021
Zoll Services LLC (A/K/A Zoll Lifecor Corp) $167.05 2019-2024 Lifevest
Ekos Corporation $146.38 2019
Janssen Pharmaceuticals, INC $146.11 2019-2023 Xarelto
Philips North America LLC $138.65 2022
Show all 21 companies
CompanyGeneral paymentsYearsTop products
Heartflow, INC. $132.67 2019-2025
Novartis Pharmaceuticals Corporation $23.90 2019
Amarin Pharma, INC. $23.76 2023
E.R. Squibb & Sons, L.L.C. $21.25 2025 Camzyos
Shockwave Medical, INC $18.91 2022
Acist Medical Systems, INC. $16.18 2024

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Mark M Gajjar

$78,476.29

in general payments reported 2019-2025

Years
2019-2025
Top company
Abbott Laboratories
Context
The $49K reported for 2025 was more than what 97% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).

https://glasscript.com/doctor/675305/mark-m-gajjar

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.